TARPLIN, DOWNS & YOUNG, LLC

Lobbying for MERCK · A research-intensive biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $50,000.00 income · posted Jul 21, 2025

Lobbying activity 3

Budget/Appropriations

Federal budget issues

Health Issues

IRA, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars, PAHPA

Medicare/Medicaid

IRA, Medicare and Medicaid payment and coverage issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.